1 |
BAO M, HUA X, MO H, et al. N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca2+ Pathway[J]. Biomolecules, 2022,12(9):1195.
|
2 |
SHENG C X, ZHANG C J, LI Y Z, et al. Effect of beta-casomorphin-7 on myocardial hypertrophy in hyperthyroidism-induced cardiomyopathy[J]. Eur Rev Med Pharmacol Sci, 2020,24(11):6380-6389.
|
3 |
WU J, ZHOU Y, LIANG C, et al. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway[J]. Chin J Integr Med, 2017,23(10):770-778.
|
4 |
ZHOU Z, CHEN S, TIAN Z, et al. miR-20b-5p attenuates hypoxia-induced apoptosis in cardiomyocytes via the HIF-1 & alpha;/NF-κB pathway[J]. Acta Biochim Biophys Sin (Shanghai), 2020,52(9):927-934.
|
5 |
温海玲, 杨景哲, 孟祥熙, 等. miR-320通过抑制TLR4/NF-κB信号通路减轻大鼠烧伤后肠道黏膜损伤[J]. 实用医学杂志, 2022,38(16):2031-2036.
|
6 |
JUNG S Y, SHIN J I, CHOI J Y, et al. Velocity Vector Imaging Assessment of Functional Change in the Right Ventricle during Transcatheter Closure of Atrial Septal Defect by Intracardiac Echocardiography[J]. J Clin Med, 2020,9(4):1132.
|
7 |
TOBIN G, CHACKO A G, SIMON R. Evaluation of NT-ProBNP as a marker of the volume status of neurosurgical patients developing hyponatremia and natriuresis: A pilot study[J]. Neurol India, 2018,66(5):1383-1388.
|
8 |
NASSER M I, ZHU S, CHEN C, et al. A Comprehensive Review on Schisandrin B and Its Biological Properties[J]. Oxid Med Cell Longev, 2020,2020:1-13.
|
9 |
YANG M, JIANG X, WANG L, et al. Schisandrin Protects against Norepinephrine-Induced Myocardial Hypertrophic Injury by Inhibiting the JAK2/STAT3 Signaling Pathway[J]. Evid Based Complement Alternat Med, 2021,2021:1-8.
|
10 |
HOU R, JIN X, GAO Y, et al. Evaluation of the Effects of Schisandra chinensis on the Myocardium of Rats with Hyperthyroid Heart Disease by Using Velocity Vector Imaging Combined with the Estimation of p53 Expression and Calmodulin Activity[J]. Evid Based Complement Alternat Med, 2020,2020:5263834.
|
11 |
OSUNA P M, UDOVCIC M, SHARMA M D. Hyperthyroidism and the Heart[J]. Methodist Debakey Cardiovasc J, 2017,13(2):60-63.
|
12 |
KHAN R, SIKANDERKHEL S, GUI J, et al. Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure[J]. Cardiol Res, 2020,11(2):68-75.
|
13 |
WU J, ZHOU Y, LIANG C, et al. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway[J]. Chin J Integr Med, 2017,23(10):770-778.
|
14 |
ZHANG W, SUN Z, MENG F. SCHISANDRIN B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis[J]. Inflammation, 2017,40(6):1903-1911.
|
15 |
SHI H, TANG H, AI W, et al. Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis[J]. Front Pharmacol, 2021,12.
|
16 |
蒋晓, 张龙, 陈涵, 等. 甲状腺相关激素水平变化对甲状腺单侧腺叶切除术的疗效评估及预后预测价值[J]. 实用医学杂志, 2022,38(9):1108-1113.
|
17 |
SCHMITT W, RÜHS H, BURGHAUS R, et al. NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure[J]. Clin Pharmacol Ther, 2021,110(2):498-507.
|
18 |
ZHUANG J, ZHU J, DOU Y, et al. Shenqi Lixin Decoction improves cardiac function in rats with adriamycin-induced heart failure through modulation of PGC-1α and mitochondrial apoptosis pathway[J]. Ann Transl Med, 2021,9(20):1592.
|
19 |
KARABULUT D, OZTURK E, KAYMAK E, et al. Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats[J]. J Biochem Mol Toxicol, 2021,35(1).
|
20 |
ZHU S, WANG Y, LIU H, et al. Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-κB p65 Pathway Both In Vitro and In Vivo[J]. Mediators Inflamm, 2019,2019:1-10.
|
21 |
ZENG N, JIAN Z, ZHU W, et al. KLF13 overexpression protects sepsis-induced myocardial injury and LPS-induced inflammation and apoptosis[J]. Int J Exp Pathol. 2023, 104(1):23-32.
|
22 |
胡琳, 杨艳娟, 李洁滢, 等. 红景天苷通过激活PI3K/Akt和抑制NF-κB信号通路改善川崎病冠状动脉损伤[J]. 实用医学杂志, 2022,38(21):2657-2662.
|
23 |
ZHU D, MA Y, WANG X, et al. Application of velocity vector imaging (VVI) in the evaluation of left ventricular myocardial contractile strain and dyssynchrony before and after stent implantation in patients with coronary heart disease[J]. Ann Palliat Med, 2021,10(7):8034-8042.
|
24 |
WANG Y, ZHANG Y, LIANG W, et al. Evaluation of eSie VVI Technology on Left Ventricular Systolic Function Changes in Uremic Patients Undergoing Dialysis[J]. J Med Syst, 2019,43(5):129.
|
25 |
YOON S J, PARK S, CHOI E Y, et al. Left Atrial Velocity Vector Imaging Can Assess Early Diastolic Dysfunction in Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy[J]. J Cardiovasc Imaging, 2023,31(1):41-48.
|